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Abstract 
Context 
A detailed understanding of renal surgical anatomy is necessary to optimize preoperative planning 
and operative technique and provide a basis for improved outcomes. 
Objective 
To evaluate the literature regarding pertinent surgical anatomy of the kidney and related structures, 
nephrometry scoring systems, and current surgical strategies for partial nephrectomy (PN). 
Evidence acquisition 
A literature review was conducted. 
Evidence synthesis 
Surgical renal anatomy fundamentally impacts PN surgery. The renal artery divides into anterior 
and posterior divisions, from which approximately five segmental terminal arteries originate. The 
renal veins are not terminal. Variations in the vascular and lymphatic channels are common; thus, 
concurrent lymphadenectomy is not routinely indicated during PN for cT1 renal masses in the 
setting of clinically negative lymph nodes. Renal-protocol contrast-enhanced computed tomography 
or magnetic resonance imaging is used for standard imaging. Anatomy-based nephrometry scoring 
systems allow standardized academic reporting of tumor characteristics and predict PN outcomes 
(complications, remnant function, possibly histology). Anatomy-based novel surgical approaches 
may reduce ischemic time during PN; these include early unclamping, segmental clamping, tumor-
specific clamping (zero ischemia), and unclamped PN. Cancer cure after PN relies on complete 
resection, which can be achieved by thin margins. Post-PN renal function is impacted by kidney 
quality, remnant quantity, and ischemia type and duration. 
Conclusions 
Surgical renal anatomy underpins imaging, nephrometry scoring systems, and vascular control 
techniques that reduce global renal ischemia and may impact post-PN function. A contemporary 
ideal PN excises the tumor with a thin negative margin, delicately secures the tumor bed to 
maximize vascularized remnant parenchyma, and minimizes global ischemia to the renal remnant 
with minimal complications. 
Patient summary 
In this report we review renal surgical anatomy. Renal mass imaging allows detailed delineation of 
the anatomy and vasculature and permits nephrometry scoring, and thus precise, patient-specific 
surgical planning. Novel off-clamp techniques have been developed that may lead to improved 
outcomes. 
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1. Introduction 
The incidence of renal tumors has been increasing over the past several decades [1]. The majority of 
these tumors are diagnosed at clinical stage T1 [2] and are amenable to partial nephrectomy (PN), 
which is the accepted surgical treatment. More recently, minimally invasive PN has become a 
viable alternative to open PN (OPN) and is routinely performed at many centers worldwide [3]. 
Much effort has been made to integrate the anatomy of the renal mass and its vasculature into 
current concepts [4] and [5]. A detailed understanding of surgical anatomy is necessary to optimize 
preoperative planning and operative technique, thus providing a basis for maximizing oncologic and 
functional outcomes. The purpose of this article is to provide a contemporary overview of renal 
surgical anatomy and anatomy-based issues for PN surgery, such as imaging, nephrometry scoring 
systems, novel vascular control techniques that reduce global renal ischemia, and factors impacting 
post-PN function and oncologic outcomes. 
2. Evidence acquisition 
The Medline, Embase, and Web of Science databases were searched without time limit on August 
1, 2014 using the terms “partial nephrectomy” OR “nephron-sparing surgery” in conjunction with 
“anatomy” (MeSH), “ischemia”, “renal function”, “margin”, “adrenalectomy”, 
“lymphadenectomy”, OR “complications”. Both free-text protocols and medical subject headings 
(MeSH) were used in Medline, while free-text protocols were run in Embase and Web of Science. 
Autoalerts in Medline were also run, and reference lists of original articles, review articles, and 
book chapters were searched for further eligible articles. The search was limited to the English 
literature. Articles that did not address the topics were excluded, and the full text of the remaining 
articles was reviewed. A list of articles that were judged to be highly relevant by the junior and 
senior authors was circulated among the coauthors, and a final consensus was reached on the 
structure of this review and the articles included. In addition, during writing of the manuscript, 
pertinent contemporary articles were identified in an attempt to include the most recent data. 
3. Evidence synthesis 
3.1. Surgical anatomy of the kidney 
The right kidney is located approximately 1–2 cm lower than the left kidney because of the location 
of liver. The diaphragm covers the upper third of the kidneys posteriorly, where there is also a close 
relationship to the pleura that extends to the level of the 12th rib. Anteriorly, the right kidney is 
bordered by the liver and the right colonic flexure. The descending part of the duodenum with the 
head of pancreas overlies the right renal hilum. The left kidney is bordered anteriorly by the left 
colonic flexure. The left renal hilum is in close anatomic relation to the body of the pancreas and 
the splenic vessels. The upper pole of the kidneys abuts the adrenal gland, which may cap the 
kidney or cradle the renal hilum, especially on the left. The posterior aspect of the kidney lies on the 
psoas muscle [6]. Therefore, it is important to realize that the upper pole lies medially and in a 
posterior plane relative to the lower pole. Computed tomography (CT) slices are commonly 
recorded at a right angle to the body, but because of the aforementioned angulation of the kidney, 
this is not necessarily at right angles to the kidney. Thus, an upper-pole tumor may occasionally 
appear on CT scan images as a mid-renal tumor. Therefore, for accurate imaging, appropriate 
adjustment of cross-sectional CT slices is required, taking into account the angulation of the kidney. 
Gerota's fascia encloses the kidney, adrenal gland, and perinephric fat. Its layers are fused 
superiorly, laterally, and medially, but not inferiorly. Classically, the structures of the renal hilum 
are, from anterior to posterior, a single renal vein, a single renal artery, and the renal pelvis. The 
hilar region is rotated somewhat anteriorly because of the psoas muscle [7] and [8]. 
3.1.1. Arterial system 
In approximately 75% of cases, a single renal artery arises bilaterally from the lateral portion of the 
abdominal aorta immediately caudal to the origin of the superior mesenteric artery. Duplication of 
renal arteries is more common on the right side (Fig. 1); duplicate arteries are often similar in 
caliber, with the exception of accessory renal arteries, which occur in approximately 25% of 
patients. These accessory arteries usually arise from the aorta and commonly subtend the poles. An 
accessory artery is defined as any supernumerary artery that reaches the kidney. If the artery does 
not enter the kidney at the hilum (eg, enters the parenchyma at a pole), it is called aberrant. An 
accessory artery may therefore be aberrant (but is not always so). Accessory arteries to the upper 
pole are typically smaller in diameter than those to the lower pole. The right renal artery passes 
behind the inferior vena cava (IVC) and is typically posterior and superior to the left and right renal 
veins. In approximately 30% of cases, the renal artery is located anterior to the renal vein. The left 
renal artery is higher than the right [6] and [9]. 
 
Fig. 1.  
Computed tomography scan showing two right renal arteries. Courtesy of V. Ficarra, 
University of Udine, and V. Macchi, University of Padua. 
Figure options 
In relation to the renal pelvis, the renal artery forms an anterior division, which carries 75% of the 
blood supply, and a posterior division, which carries 25% of the blood supply. These divisions are 
most often formed outside the renal hilum [9]. Extra- and intraparenchymal arterial sections can be 
distinguished (Fig. 2). Along the lateral border of the kidney, between the arterial divisions, lies the 
avascular plane (Brödel's line), which is located in the axis of the posterior. This avascular plane is 
not in the exact mid-lateral portion of the kidney, but is located slightly posteriorly. Brödel's line 
can be used for avascular access for anatrophic nephrolithotomy and for endophytic tumors. 
 
Fig. 2.  
Anatomy of the left renal artery. Extra- and intraparenchymal arterial sections are 
distinguished. Courtesy of V. Ficarra, University of Udine, and V. Macchi, University of 
Padua. 
Figure options 
From the arterial divisions, five segmental arteries originate, including an apical, upper, middle, 
lower, and posterior segmental artery (Fig. 3) [10]. The first four segmental arteries arise from the 
anterior division, and the last segmental branch arises from the posterior division. Segmental 
arteries are end arteries and do not provide adequate collateral circulation. Ligation of a segmental 
artery causes irreversible ischemia to that segment of the kidney and subsequent segmental renal 
infarction. This involves limited parenchymal areas in the case of an anterior segmental artery, but 
occlusion of the posterior segmental artery can result in infarction of almost the entire posterior 
aspect of the kidney. A high percentage of patients shows anatomic variants of Graves’ initial 
classification [10], especially for the lower segmental artery, which may arise from the main renal 
artery, its anterior division, the upper segmental artery, or as an accessory artery from the 
abdominal aorta [6]. 
 
Fig. 3.  
Graves’ anatomic classification of segmental renal arteries. In addition to the classical 
variant, a high percentage of patients show anatomic variations. Courtesy of V. Ficarra, 
University of Udine, and V. Macchi, University of Padua. 
Figure options 
Segmental arteries give rise to interlobar arteries at the level of the fornix, and these continue in the 
interlobar septae between the pyramids. At the corticomedullary junction, each interlobar artery 
branches into five to seven arcuate arteries, which in turn branch into interlobular arteries. 
Interlobular arteries supply the afferent glomerular arteries. 
3.1.2. Venous system 
The peritubular capillary venous plexus drains through venae rectae into the arcuate veins. Similar 
to the arterial system, arcuate veins drain into the interlobular vein, which forms several trunks (two 
in ∼50%, three in ∼30% of cases) that unite as the renal vein anterior to the renal pelvis. 
Anastomotic longitudinal venous arcades are present within the kidney. These veins are not 
terminal, so the major branches can be surgically ligated without the risk of venous obstruction. A 
retropelvic vein, which drains some of the posterior part of the kidney, is present in two-thirds of 
cases [6]. 
The right renal vein drains directly into the IVC. There are usually no tributaries; rarely, the right 
gonadal vein may drain into the right renal vein. Duplication is found in 15–20% of cases. In 
contrast to the arterial system, isolated accessory polar veins are a rarity. The left renal vein is 
approximately two to three times longer than the right renal vein, enters the IVC anterior to the 
aorta, and is infrequently duplicated. In such instances, a retroaortic left renal vein may be present, 
and is often circumaortic to reflect branches anterior and posterior to the aorta. Left renal vein 
tributaries include the gonadal vein, adrenal vein, inferior phrenic veins, the first or second lumbar 
veins, and paravertebral veins in one-third of cases. The rich anastomotic structure makes it possible 
to ligate the left renal vein medially via IVC occlusion in the case of an IVC thrombus for a right-
sided renal cell carcinoma (RCC) or during surgery for an abdominal aortic aneurysm [6]. 
3.1.3. Radially oriented intrarenal architecture 
The intrarenal anatomy is radially oriented. This fact can be taken advantage of when performing 
PN. The intrarenal arteries, veins, and calyces fan out radially from the renal hilar sinus towards the 
lateral convex border of the kidney. Thus, a radial nephrotomy incision during unclamped PN is 
less likely to transect a major intrarenal vessel, and may therefore result in less bleeding than for a 
nonradial incision. In addition, the renal parenchyma and pyramids are similarly radially oriented. 
Therefore, during enucleative PN, an appropriate enucleative plane can typically be identified and 
then developed bluntly in close vicinity to the tumor capsule. This radially oriented parenchyma 
lends itself to atraumatic blunt separation of the renal parenchyma rather than sharp cutting. 
3.1.4. Kidney tumor-parenchyma interface 
During enucleative PN, excision is performed immediately adjacent to the tumor edge. To better 
inform the anatomic and oncologic propriety of enucleative PN, histologic examination of the 
tumor-parenchyma interface was performed on 124 nephrectomy specimens [11]. Some 82% of 
malignant tumors had an intrarenal pseudocapsule (PC) with a median thickness of 0.6 mm. PC 
invasion was noted in 45% of the cancers overall; however, no patient had a positive surgical 
margin. Inflammation, nephrosclerosis, glomerulosclerosis, and arteriosclerosis decreased with 
increasing distance from the tumor edge. The mean arteriolar diameter decreased with tumor 
proximity. The authors concluded that PN excision adjacent to the tumor edge appears to be 
histologically safe. Since the peritumoral parenchyma is histologically altered/compressed with 
fewer/smaller arterioles, this appears to be a surgically favorable plane for enucleative PN. Since 
18% of cancers lacked an intrarenal PC and 25% of pT1a cancers had intrarenal PC invasion, 
extreme care is necessary to avoid positive margins during enucleative PN [11]. 
3.2. Partial nephrectomy planning 
3.2.1. Imaging of renal tumors and the vascular system 
An understanding of the renal anatomy and vasculature is necessary for preoperative surgical 
planning. Imaging must delineate the relationship of the mass to adjacent normal structures and 
demonstrate the vascularity of the tumor. 
Bi- or triphasic contrast-enhanced CT of the abdomen is the reference standard for primary imaging 
and staging. According to the American College of Radiology Practice Guidelines, the CT slice 
thickness should be 5 mm or less [12]. Masses are classified as solid or cystic, with 
subclassification of the latter according to Israel and Bosniak [13]. The multidetector CT (MDCT) 
protocol includes a non-contrast phase, a corticomedullary phase (after 40 s), a nephrographic phase 
(90 s), and a urographic phase (7 min). Enhancement of >15–20 Hounsfield units (HU) is 
considered the most important indicator of malignancy and is best assessed in the nephrographic 
phase. The corticomedullary phase is used to assess the arterial system (number of renal arteries, 
feeding mass arteries) and the urographic phase to assess proximity to and involvement of the renal 
collecting system [14]. Three-dimensional CT reconstruction depicts the vascular and renal mass 
anatomy in a format familiar to surgeons and serves to guide PN surgery, especially in complex 
cases [15] and [16]. 
Although CT remains the standard for primary imaging of renal masses, it has limited ability to 
characterize masses of <1 cm in diameter and carries radiation exposure [14]. Dual-energy CT 
(DECT) has the potential to lower radiation exposure by approximately 50%. DECT involves 
simultaneous acquisition of CT data at two different energy settings. Different materials show 
distinct attenuation levels at a given energy setting, allowing for material decomposition [14]. If 
iodine is removed from the post-contrast image, a virtual non-contrast image is acquired. For 
characterization of renal masses, DECT has similar accuracy to conventional two-phase CT 
examinations with a true non-contrast phase [17]. Although initial data are convincing, DECT 
technology is not yet broadly available and further data are required. 
Macroscopic fat (less than –20 HU) can generally be observed on CT scans of angiomyolipomas, so 
these can be differentiated from other renal tumors. It is important to note that the fat content may 
be difficult to diagnose in small angiomyolipomas because of the volume averaging effect and a 
proportion of angiomyolipomas are fat-poor. Oncocytomas are typically hypervascular and 
homogeneous and may have a characteristic central stellate scar; however, CT features cannot 
reliably distinguish an oncocytoma from other renal tumors [18]. Papillary and chromophobe RCCs 
generally exhibit lower and more heterogeneous enhancement than clear-cell RCC [19] and [20], 
but subtypes are more difficult to differentiate in small masses. In terms of tumor size, studies 
indicate that CT imaging overestimates pathologic size by a small amount. The size tends to be 
overestimated small tumors and underestimated for larger tumors [21]. 
Magnetic resonance imaging (MRI) is an alternative imaging procedure and is commonly used as a 
problem-solving tool in patients with indeterminate CT scans (eg, for complex cystic lesions, very 
small masses, enhancement of 10–20 HU) or contrast medium allergies [22]. Compared to CT, MRI 
may be better for detecting perirenal fat invasion and evaluating the cranial and caudal extent of a 
venous thrombus in the IVC, as well as delineating benign thrombus from tumor thrombus [14]. 
Functional and advanced imaging techniques such as diffusion-weighted and perfusion-weighted 
imaging are expected to expand the role of MRI in the future [23]. 
Renal ultrasound can distinguish cystic from solid masses, may assist in identifying 
angiomyolipoma, and can show vascularity with the additional use of ultrasound contrast agents, 
including microbubbles. Because it is both less accurate than CT or MRI and user-dependent, 
ultrasound has a limited role in preoperative surgical planning [24]. Furthermore, assessment of the 
IVC and retroperitoneal nodes is often limited by bowel gas and body habitus [14]. Intraoperative 
ultrasound is most commonly used for intraoperative localization, to screen for additional small 
lesions, to confirm ischemia following clamping, to assist in obtaining negative resection margins 
during PN, to enable renal mass biopsy, and to guide probe placement for thermal ablation. 
Intraoperative ultrasound reveals additional findings not observed on preoperative imaging in 
approximately 10% of patients undergoing PN. This alters surgical management in the majority of 
cases [25]. 
3.2.2. Nephrometry scoring systems 
Anatomy-based nephrometry scores are assigned from preoperative imaging and delineate renal 
mass characteristics and the relationship to adjacent structures [26]. Use of standardized objective 
and reproducible measures minimizes interobserver variability. Nephrometry scores can inform the 
surgeon regarding technical difficulty during PN for a given mass, and have been correlated with 
ischemia time, operation time, blood loss, complications, and the likelihood of conversion from PN 
to radical nephrectomy (RN). Nephrometry scoring systems can assist in clinical decision-making 
on RN versus PN or open versus minimally invasive PN [27]. 
3.2.2.1. RENAL score 
The RENAL nephrometry score consists of five anatomic radiologic properties: (R)adius/maximal 
tumor diameter, (E)xophytic/endophytic properties, (N)earness to the collecting system or sinus, 
(A)nterior(a)/posterior(p)/not anterior or posterior (x) descriptor, and (L)ocation relative to the polar 
line. The polar lines are defined by the planes in which the medial lip of parenchyma is first seen. 
The suffix hilar (h) is added for tumors that abut the main renal artery or vein (Table 1) [28]. 
Table 1.  
Overview of the parameters of the RENAL and PADUA scoring systems 
Variable RENAL PADUA 
Maximal tumor 
diameter 
1 point: ≤4 cm 
2 points: >4 – <7 cm 
3 points: ≥7 cm 
1 point: ≤4 cm 
2 points: 4–7 cm 
3 points: >7 cm 
Exophytic/endophytic 
rate 
1 point: ≥50% 
2 points: <50% 
3 points: endophytic 
1 point: ≥50% 
2 points: <50% 
3 points: endophytic 
Collecting system 
Or renal sinus 
1 point: proximity >7 mm 
2 points: proximity 4–7 mm 
1 point: not involved 
2 points: 
dislocated/infiltrated 
Variable RENAL PADUA 
3 points: proximity ≤4 mm 
Polar location 
1 point: entirely above or below the polar 
lines
a
 
2 points: crosses the polar line 
3 points: >50% crosses the polar line or 
crosses the axial renal midline or entirely 
between the polar lines 
1 point: 
superior/inferior 
b
 
2 points: middle 
Renal rim – 
1 point: lateral 
2 point: medial 
Renal sinus Included in collecting system 
1 point: not involved 
2 points: involved 
Anterior/posterior No points No points 
a 
Polar lines are defined as the plane of the kidney above or below which the medial lip of 
parenchyma is interrupted by the renal sinus fat, vessels, or the collecting system on axial 
imaging. 
b 
Polar lines are defined according to the renal sinus. 
Table options 
For each variable except A, one to three points are assigned, which yield a total of 3 points for the 
least complex and 12 points for the most complex mass. The score is read as each individual 
variable (eg, 1 + 2 + 2 + A + 3) summed to a score and followed by the polar location (eg, 8A). 
Masses are classified as low complexity (RENAL score 4–6), moderate complexity (score 7–9), or 
high complexity (score 10–12). An online tool has been developed to facilitate calculation at the 
point of care (www.nephrometry.com). 
3.2.2.2. PADUA classification 
The Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) classification consists 
of six scoring parameters and an anterior/posterior descriptor. The variables include polar location, 
exophytic/endophytic rate, renal rim, involvement of the renal sinus, involvement of the urinary 
collecting system, and maximal tumor size (Table 1) [29]. The polar lines are defined as the upper 
and lower margins of the renal sinus fat. The classification is given as a single sum of these 
parameters, with a minimum score of 6 and a maximum of 14. Stratification may be according to 
low complexity (score 6–7), moderate complexity (score 8–9), or high complexity (score 10–14) 
given the fact that this correlates with the risk of overall complications [29]. 
3.2.2.3. Centrality index 
The centrality index (CI) differs substantially from the RENAL score and PADUA classification. CI 
is a continuous index based on tumor size and distance from the periphery of the tumor to the center 
of the kidney [30], which are thought to be the most important factors that determine resection 
difficulty. CI is defined as the ratio of c to the tumor radius r (diameter/2). The variable c equalizes 
the distance from the tumor center to the kidney center and may be calculated according to the 
Pythagorean theorem on axial images. For a tumor in the kidney center, CI = 0. CI increases with 
increasing distance of the tumor periphery from the kidney center, and surgical resection becomes 
easier. An online spreadsheet facilitating CI calculations is available 
(http://my.clevelandclinic.org/Documents/Urology/CentralityIndex2.xls). 
3.2.2.4. Contact surface area 
The larger the surface area of contact between a tumor and its surrounding uninvolved renal 
parenchyma, the greater are the amount of kidney tissue excised and the extent of renorrhaphy 
required during PN surgery. Contact surface area (CSA) is a descriptive, CT-based radiologic data 
point that may better reflect tumor complexity by numerically combining two important aspects, 
tumor size and percentage endophytic component, into a single radiologically measurable 
parameter. Using three-dimensional rendering software, the tumor circumference and its 
intraparenchymal component are manually rendered. Image-processing software then automatically 
calculates the volume of the tumor and its intraparenchymal component. The total surface area 
(TSA) of the tumor is calculated using the formula 4πr2 (r = tumor radius). CSA is derived by 
multiplying TSA by the percentage intraparenchymal component. For 162 tumors, CSA >20 cm
2
 
predicted adverse tumor characteristics (greater tumor size, volume, complexity) and perioperative 
outcomes (more parenchymal volume loss, blood loss, complications) compared to CSA <20 cm
2
. 
Interobserver concordance of CSA was excellent [31]. 
3.2.2.5. Summary of studies on nephrometry scoring systems 
As shown in Table 1, there are few differences in the RENAL and PADUA scores for a given renal 
mass. The scores are highly correlated (correlation coefficient 0.8) [32]. Both systems assign almost 
the same points for maximal tumor size. The only difference is for a tumor with a maximal size of 
7.0 cm, which would be scored as 2 according to RENAL and 3 according to PADUA. In the 
PADUA classification, the renal sinus and collecting system are scored separately on a scale of 1–2, 
compared to a single three-tiered variable in the RENAL system. Because of differing definitions of 
polar lines, the polar location may be assigned differently (Table 1). The two systems show good 
agreement, with correlation of 0.7–0.9 [33], [34], [35], [36] and [37]. Although CI contains only 
two variables, the coefficients for correlation with the RENAL and PADUA scores are remarkable 
(0.4–0.6) [32]. While CSA correlates well with the RENAL, PADUA, and CI systems, initial data 
suggest that CSA may be more accurate in predicting certain perioperative events [31]. 
There have been numerous studies on nephrometry scoring systems. Detailed descriptions are 
beyond the scope of this article. Although there are conflicting data, the majority of studies indicate 
that the systems are similarly effective in predicting the risk of overall complications, estimated 
blood loss, length of hospital stay, and ischemia time (Table 2). Several reports have correlated 
nephrometry scores with postoperative renal function [32], [34] and [38]. 
Table 2.  
Selected validation studies for the RENAL score, PADUA classification, and C index 
Reference n Complications 
Ischemia 
time 
Blood 
loss 
LOS 
RENAL score 
Hayn et al [112] 141 LPN NS + + + 
Simhan et al [96] 216 OPN, 174 RPN Major (CCS 3–5) + + + 
Reference n Complications 
Ischemia 
time 
Blood 
loss 
LOS 
Hew et al [33] 134 PN + + NA NA 
Kruck et al [113] 81 LPN NS NS + + 
Lavallée et al [35] 78 OPN NA + NA NA 
Bylund et al [32] 
124 LPN, 25 RPN, 13 
OPN 
NA + + NA 
Png et al [36] 83 RPN NS + NS NA 
Long et al [114] 159 OPN, 18 LPN NS NS NS NS 
Stroup et al [106] 
153 OPN, 100 LPN, 
31 RPN 
Urine leak, but NS 
overall 
NA NA NA 
Mayer et al [115] 55 RPN, 12 LPN NA + NS NA 
Liu et al [95] 128 LPN, 53 RPN + + NS NS 
Altunrende et al 
[116] 
181 RPN NA NS NA NA 
Mufarrij et al 
[117] 
92 RPN NS 
Trend 
(p = 0.07) 
Trend 
(p = 0.07) 
NS 
Bruner et al [118] 155 PN Urine leak NA NA NA 
Okhunov et al [34] 101 LPN NS + NS NS 
PADUA classification 
Hew et al [33] 134 PN + + NA NA 
Kruck et al [113] 81 LPN – NS + + 
Lavallée et al [35] 78 OPN NA + NA NA 
Bylund et al [32] 
124 LPN, 25 RPN, 13 
OPN 
NA + NS NA 
Okhunov et al [34] 101 LPN NS + NS NS 
Ficarra et al [94] 347 RPN + + + NA 
Waldert et al [119] 186 OPN, 54 LPN + + NA NA 
Kong et al [120] 136 OPN, 59 LPN + + NS NA 
Mottrie et al [121] 62 RPN + + + NA 
Tyritzis et al [122] 74 OPN + NA NA NA 
Minervini et al 
[123] 
244 OPN + NA NA NA 
C index 
Lavallée et al [35] 78 OPN NA 
Trend 
(p = 0.06) 
NA NA 
Bylund et al [32] 
124 LPN, 25 RPN, 13 
OPN 
NA + NS NA 
Okhunov et al [34] 101 LPN NS + NS + 
LOS = length of hospital stay; LPN = laparascopic partial nephrectomy; OPN = open partial 
nephrectomy; RPN = robot-assisted partial nephrectomy; + = statistically significant 
association; NS = not significant; NA = not assessed; CCS = Clavien-Dindo classification 
system. 
Table options 
Nephrometry parameters have been associated with pathological factors. Based on parameters of 
the RENAL score, nomograms predicting malignancy and high grade were developed [39]. For 
both nomograms, maximal tumor size (variable R) was the most important nephrometric variable. 
The area under the curve was 73% and 76% for malignancy and high grade, respectively. External 
validation revealed an area under the curve of 73% for prediction of high-grade disease [40]. 
Likewise, recent studies showed that higher tumor complexity according to the RENAL score is 
associated with high-grade disease and clear-cell subtype [41] and [42]. 
3.3. Optimizing PN outcomes 
3.3.1. Optimizing functional outcomes of PN 
Multiple factors impact renal functional outcomes after PN, including preoperative renal function, 
comorbidity, age, gender, tumor size, percentage volume preservation, and ischemia time [43]. 
Overall, the two surgically relevant principles for optimizing post-PN functional outcomes are to 
maximize volume preservation and minimize ischemia. The volume of parenchyma preserved is 
potentially more important than short-duration ischemia time, especially in healthy patients with 
normal function at baseline [44] and [45]. 
3.3.1.1. Maximizing volume preservation 
As discussed in Section 3.3.2, the margin width should be minimized while ensuring a negative 
margin [3]. Generalized through-and-through oversuturing of the PN bed may be minimized to 
reduce ischemic damage to adjacent healthy remnant parenchyma, although this concept has not 
been proven. Suturing of the PN bed may even be avoided in selected cases [46]. There are several 
methods available to evaluate the amount of renal parenchyma preserved. Subjective surgeon 
assessment of preserved volume may provide an estimate comparable to more time-consuming 
imaging techniques, including cylindrical measurements obtained from preoperative and 
postoperative CTs [47] or three-dimensional imaging [48]. 
3.3.1.2. Minimizing ischemia 
During PN, the main artery is routinely clamped to minimize blood loss and create a relatively 
bloodless field for tumor excision and renal reconstruction. However, arterial clamping leads to 
ischemic damage of the renal parenchyma. Several models have been proposed to study the effects 
of ischemia on renal function, such as the solitary kidney [49]. There is no agreement on the precise 
cutoff time for the onset of durable renal damage during warm ischemia [50], [51], [52] and [53]. 
Ischemia time should be interpreted as a continuum whereby increasingly prolonged ischemia times 
are more likely to cause acute kidney dysfunction [49] and [53]. A recent report indicated that 
patients with baseline medical chronic kidney disease had worse long-term outcomes after PN than 
those with surgically induced chronic kidney disease [54]. Elderly patients with comorbidities 
(diabetes, hypertension) and pre-existing renal dysfunction at baseline are likely to have 
compromised kidneys with glomerulonephro-arteriosclerosis due to medical renal disease. These 
compromised kidneys are proboably more acutely susceptible to even shorter ischemic insults 
compared to healthy younger individuals with normal kidney function at baseline. Thus, recent 
efforts continue to be directed towards minimizing ischemic injury. 
The classical strategy to limit ischemic damage is the induction of hypothermia (cold ischemia). 
Surface cooling with ice slush decreases renal energy expenditure and partly ameliorates the 
adverse impact of warm ischemia and reperfusion injury [55] and [56]. A nonrandomized 
comparative study revealed a similar decrease in glomerular filtration rate (GFR) at 3 mo after 
warm or cold ischemia, although the median cold ischemia time was substantially longer (45 vs 
22 min) [44]. Many surgeons prefer to use mannitol and/or furosemide during PN, which may 
optimize reperfusion and increase diuresis [57]. However, several recent studies do not support the 
use of mannitol during PN [58], even in solitary kidneys [59]. Cooling with ice slush is the classical 
strategy for cold ischemia during OPN [56], but has also been applied in minimally invasive 
approaches [60] and [61]. 
As routine induction of cold ischemia is still technically arduous, several anatomic methods have 
been proposed to reduce the extent and duration of warm ischemia. From a practical perspective, 
the most technically relevant, surgically modifiable factor that impacts remnant function after PN is 
the duration or extent of ischemia. Global renal ischemia time is significantly reduced by early 
unclamping of the main renal artery, which is performed immediately after placement of the initial 
central running suture [62]. Compared to standard clamping in PN, warm ischemia times are 
reduced by >50% (mean 31.1 vs 13.9 min), while estimated blood loss and bleeding complications 
are similar [62]. In another study, mean warm ischemia time was reduced from 28 to 18.5 min [63]. 
Clamping of the main artery results in the greatest ischemic insult, which can be reduced by 
selective clamping of only the pertinent segmental artery(ies) [64]. The selective clamping 
technique is primarily used in minimally invasive PN, but Nohara et al [65] were also able to apply 
selective arterial clamping during OPN; however, a segmental renal artery could be isolated in only 
half of cases. Selective arterial clamping may not be feasible in certain instances such as dense or 
adherent perirenal fat or short segmental arteries [64]. 
Clamping of distally located, tumor-specific, higher-order segmental renal artery branches in 
minimally invasive PN has been described [66]. Zero-ischemia PN refers to superselective 
clamping of tumor-specific tertiary or quaternary artery branches. In another series, this was 
performed successfully in 84% of patients undergoing laparascopic PN (LPN). Compared to 
clamping of the main renal artery, blood loss was greater (238 vs 154 ml), but patients who had 
segmental renal artery clamping had significantly better renal function at 3–6 mo [67] and [68]. 
Since arterial blood flow to the remnant kidney is not interrupted, global renal ischemia is 
eliminated [69] and [70]. Tumor-specific arterial branches are microdissected and superselectively 
clamped with micro-bulldog clips. Selective arterial control is confirmed intraoperatively by color 
Doppler sonography [69] and [70], hyperspectral imaging [71] and [72], or robotic vascular 
fluorescence imaging [73]. In an initial study of 15 patients, there was no change in estimated GFR 
(eGFR) [66]. Additional studies showed that the ipsilateral renal function decreased by 
approximately 10% [74]. The rate of major and minor complications was 0% and 18%, respectively 
[70], which is comparable to other techniques. Oncologic control with negative surgical margins 
was achieved in all patients [66], [70] and [74]. Zero-ischemia minimally invasive PN appears best 
suited for medially located or hilar tumors [66]. 
If the tumor has favorable anatomic features (small size, exophytic lesion, low nephrometry scores), 
PN may be performed without any vascular clamping whatsoever. Tumor excision and renal 
reconstruction are performed unclamped. This approach can reduce the incidence of acute renal 
failure in patients with a solitary kidney [75]. There have been several studies on this approach; the 
majority of tumors were removed by OPN [76] and [77]. In one report on 101 patients, LPN was 
performed without clamping and suturing; however, more than 95% of the tumors had low 
nephrometry scores. Split-renal functional outcomes at 1 yr were unchanged from preoperative data 
[46]. Studies revealed an increase in estimated blood loss for this approach without an increase in 
transfusion rates [78], whereas others seemed to show increased transfusion rates [77]. Clampless 
minimally invasive PN may be aided by prior superselective embolization of tumor-specific arteries 
[79] and [80], prior radiofrequency ablation [81], and parenchymal clamping [82] in select cases. In 
minimally invasive PN for selected tumors, a bolster can be omitted [83]. The defect can be closed 
with an intraparenchymal running suture and thrombin sealant. This obviates the need for 
parenchymal renorrhaphy suturing and shortens ischemia time. 
The issue of improving renal functional outcomes by decreasing warm ischemia time is not yet 
settled. Several studies indicate that the amount of renal parenchyma preserved, but not the type or 
duration of ischemia, is significant in multivariate analysis [44] and [45]. Conversely, a recent 
report indicated that decreasing warm ischemia times resulted in superior renal functional outcomes 
after correcting for volume loss. In serial cohorts with similar preserved parenchyma volumes and 
ischemia times of 36, 32, 15, and 0 min, actual eGFR outcomes exceeded volume-predicted eGFR 
outcomes only in the zero-ischemia cohort (–9.5%, –11%, –0.9%, and +4.2%, respectively; 
p < 0.001) [84]. Further prospective studies are necessary to clarify this issue. 
3.3.2. Optimizing oncologic outcomes of PN 
Positive surgical margins occur in approximately 3% of cases after PN [85]. Historically, a 1-cm 
rim of healthy parenchyma was recommended to allow optimal local tumor control [86]. The width 
of the negative margin does not affect local tumor control [87]. In patients with a positive margin, 
only 7% of reoperated renal remnants had viable cancer cells [88]. Thus, the width of the negative 
margin can be kept to a thin, uniform rim of normal parenchyma. Intraoperative frozen section 
analysis is not definitive and has limited clinical significance [89], so can be omitted in the setting 
of complete gross resection. 
Enucleative PN (tumor enucleation) along the natural plane between the tumor PC and renal 
parenchyma is an alternative approach for preserving the maximal amount of renal parenchyma 
[90]. There have been some doubts regarding local tumor control, but data from nonrandomized 
observational studies indicate similar oncologic outcomes compared to RN in appropriately selected 
patients [91]. However, it is noteworthy that some tumors do not have a PC, and thus may not 
qualify for enucleation [92]. Even if the tumor penetrates through the pseudocapsule in healthy 
parenchyma, enucleation with a negative margin status can be achieved [93]. Enucleation may be 
accompanied by diathermy or laser ablation of the tumor bed. 
3.3.3. Minimizing PN complications 
The two main procedure-related renal complications of PN are hemorrhage and urinary leakage. 
Risk factors for complications can be classified as anatomic, surgical, or patient-related. Anatomic 
risk factors are summarized in the nephrometry scoring systems, which correlate with the overall 
risk for complications [94], [95] and [96]. Anatomic and patient-related factors cannot be modified, 
but can guide the surgical approach. 
The incidence of complications is well documented in the prospective EORTC 30904 trial. 
Perioperative blood loss was <0.5 l in 17.1%, 0.5–1.0 l in 9.7%, and >1.0 l in 3.1% of cases [97]. In 
addition to coagulopathy and intraoperative vascular injuries as patient-related and surgical risk 
factors, proximity to the collecting system [95] and tumor size [98] are established anatomic risk 
factors for perioperative hemorrhage (intra- and postoperative). In a multicenter study of 730 
elective OPNs, the rate of blood transfusions for tumors ≤4 cm and >4 cm was 6.3% and 14.8%, 
respectively [98]. ASA score ≥3 (OR 2.9) and smoking (OR 3.5) were identified as additional 
patient-related risk factors for blood transfusion following LPN [99]. LPN appears to be associated 
with lower intraoperative blood loss, but a higher rate of postoperative hemorrhage [100]. Most 
patients with postoperative hemorrhage can be managed conservatively; some require embolization 
and a minority need reoperation [100] and [101]. Precise operative technique and intraoperative 
hemostasis are cornerstones in preventing postoperative hemorrhage. Hemostatic agents and tissue 
sealants are frequently used as an adjunct to conventional hemostasis by coagulation and suturing, 
especially after LPN [102]. They improve hemostasis [103] and [104], but there is a lack of data 
from randomized studies. 
Urinary leakage occurs in approximately 4–5% of cases [97] and [105]. Proximity to the collecting 
system, and thus a higher nephrometry score, is associated with postoperative urinary leakage [106]. 
Tumor size is another main risk factor, with the incidence increasing twofold for tumors >2.5 cm 
[105]. Urinary leakage can be managed conservatively with a ureteral stent or percutaneous 
drainage [101]. Preoperative insertion of a ureteral catheter allows retrograde filling to identify 
opening of the urinary collecting system, although this did not decrease the rate of postoperative 
urine leaks [107]. A renal pelvic anatomy score (RPS) has been developed [108] and validated 
[96] and [109]. The RPS is defined as the percentage of renal pelvis inside the renal parenchyma 
volume, categorized as intraparenchymal (>50%) or extraparenchymal (<50%) renal pelvis. 
Intraparenchymal renal pelvic anatomy is associated with a markedly higher risk of urinary leakage, 
which in turn may guide perioperative management [108] and [109]. 
Reporting of composite outcomes of PN using a trifecta system (negative margins, functional 
preservation, no urologic complications) has recently been proposed and is likely to increase in 
relevance [84]. Importantly, the definition of trifecta outcomes is not standardized and several 
different criteria have been used [84], [110] and [111]. 
4. Conclusions 
Over the past decade, PN surgery has been evolving towards an ideal PN. Renal mass imaging 
allows detailed delineation of the anatomy and vasculature and permits nephrometry scoring, and 
thus precise, patient-specific surgical planning. Novel techniques have been developed that 
minimize global renal ischemia during PN. A contemporary ideal PN excises the tumor with a thin 
negative margin, precisely secures the tumor bed, and reduces global ischemia to the renal remnant 
with minimal complications. 
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